ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,846.00
0.00%
다우존스 지수
40,211.72
0.53%
Bitcoin
62,985.43
-2.88%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. AMEX
  6. Synthetic Biologics Inc (SYN)

  7. Synthetic Biologics Inc (SYN) 뉴스

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:SYN
일자시간출처헤드라인심볼기업
2014/02/2707:01PR Newswire (US)Synthetic Biologics' Board of Directors Accepts Resignation of Long-Standing Founder and Board MemberAMEX:SYNSynthetic Biologics Inc
2014/02/1405:57PR Newswire (US)Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market ActivityAMEX:SYNSynthetic Biologics Inc
2014/02/1021:00PR Newswire (US)Synthetic Biologics Announces Rhonda Voskuhl, M.D., to Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results...AMEX:SYNSynthetic Biologics Inc
2014/02/0421:00PR Newswire (US)Synthetic Biologics to Present at the 2014 BIO CEO & Investor ConferenceAMEX:SYNSynthetic Biologics Inc
2014/01/2721:00PR Newswire (US)Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease ProgramsAMEX:SYNSynthetic Biologics Inc
2014/01/0904:06PR Newswire (US)Synthetic Biologics to Present at the Biotech Showcase™ 2014 ConferenceAMEX:SYNSynthetic Biologics Inc
2014/01/0903:43PR Newswire (US)Synthetic Biologics to Present at the 7th Annual OneMedForum San Francisco 2014 ConferenceAMEX:SYNSynthetic Biologics Inc
2013/12/1802:38PR Newswire (US)Synthetic Biologics Announces Closing of Public Offering of Common StockAMEX:SYNSynthetic Biologics Inc
2013/12/1211:12PR Newswire (US)Synthetic Biologics Announces Pricing of Public Offering of Common StockAMEX:SYNSynthetic Biologics Inc
2013/12/1206:11PR Newswire (US)Synthetic Biologics Announces Proposed Public Offering of Common StockAMEX:SYNSynthetic Biologics Inc
2013/12/1006:27PR Newswire (US)Synthetic Biologics and Intrexon Corporation Initiate Development of Novel Biologics for a Subset of Patients Suffering from ...AMEX:SYNSynthetic Biologics Inc
2013/12/0921:00PR Newswire (US)Synthetic Biologics' Webcast Conference Call Set for 9:00 a.m. EST this Morning, December 9thAMEX:SYNSynthetic Biologics Inc
2013/12/0803:30PR Newswire (US)Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irrit...AMEX:SYNSynthetic Biologics Inc
2013/12/0305:07PR Newswire (US)Synthetic Biologics to Present at the LD MICRO VI: Main Event Conference in Los AngelesAMEX:SYNSynthetic Biologics Inc
2013/11/1423:00PR Newswire (US)Synthetic Biologics' SYN-004 for the Prevention of C. difficile Infections Named a "Top Project to Watch" by Elsevier Busines...AMEX:SYNSynthetic Biologics Inc
2013/11/1421:00PR Newswire (US)Synthetic Biologics Reports Third Quarter 2013 Financial Results and Operational UpdateAMEX:SYNSynthetic Biologics Inc
2013/11/0804:00PR Newswire (US)Synthetic Biologics to Report Third Quarter 2013 Financial ResultsAMEX:SYNSynthetic Biologics Inc
2013/10/2523:58Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2013/10/2506:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2013/10/2423:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2013/10/2423:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
2013/10/1601:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2013/10/1520:00PR Newswire (US)Synthetic Biologics Initiates Manufacturing of SYN-004 for Use in Preclinical and Clinical Trials to Target the Prevention of...AMEX:SYNSynthetic Biologics Inc
2013/09/2422:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:SYNSynthetic Biologics Inc
2013/09/2020:00PR Newswire (US)Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"AMEX:SYNSynthetic Biologics Inc
2013/09/1020:00PR Newswire (US)Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, PolandAMEX:SYNSynthetic Biologics Inc
2013/09/1020:00PR Newswire (US)Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, PolandAMEX:SYNSynthetic Biologics Inc
2013/09/1000:50Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
2013/09/0320:00PR Newswire (US)Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York CityAMEX:SYNSynthetic Biologics Inc
2013/08/1506:59Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
 검색 관련기사 보기:AMEX:SYN

최근 히스토리

USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
NYSE
AXP
American Express
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유